Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Bora Pharmaceuticals Revenue

Bora Pharmaceuticals had revenue of 5.89B TWD in the quarter ending June 30, 2026, with 20.99% growth. This brings the company's total for the last twelve months to 19.56B, up 0.30% year-over-year. In the year 2025, Bora Pharmaceuticals had annual revenue of 19.01B with 9.11% growth. That makes Bora Pharmaceuticals the 10,202nd largest company in the world by revenue and 291st in Taiwan.

• Revenue (ttm): 19.56B
• Revenue Growth: +0.30%
• P/S Ratio: 2.69
• Revenue / Employee: n/a
• Employees: 36
• Market Cap: 53.21B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Sales Operations Department 14.77B 60.4%
• CDMO Operations Department 8.84B 36.1%
• Other Operations Department 845.31M 3.5%

By Geography

Chart

• United States 14.68B 77.2%
• Europe 2.61B 13.8%
• Taiwan 1.29B 6.8%
• Other 425.14M 2.2%

Fiscal year ended Dec 31, 2025 See the full Bora Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.01B	1.59B	9.11%
Dec 31, 2024	17.43B	3.23B	22.72%
Dec 31, 2023	14.20B	3.71B	35.31%
Dec 31, 2022	10.49B	5.59B	114.18%
Dec 31, 2021	4.90B	3.10B	172.28%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error